5.13% -0.1788

Sonoma Pharmaceuticals Inc (SNOA)

Panoramica Notizia Cronologia dei prezzi Financials Perché SNOA Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Sonoma Pharmaceuticals Inc

Healthcare (1172)

800-759-9305

5445 CONESTOGA COURT, SUITE 150, BOULDER, CA

Prossima data di guadagno

Ultimi documenti SEC

SNOA's Discussions on Twitter

Confronta SNOA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SNOA Sonoma Pharmaceuticals Inc	3.33	5.67M	12.31M	-5.08M	-5.20M	-0.94
ZTS Zoetis Inc	161.02	72.14B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.10	47.64B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.12	45.76B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	16.59	18.67B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.30	13.96B	612.78M	-86.37M	-62.91M	-0.87

Sonoma Pharmaceuticals Inc Borsa (SNOA) Ultime notizie

Sonoma Pharmaceuticals Inc Azioni (SNOA) Dati Finanziari

Sonoma Pharmaceuticals Inc (SNOA)

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Confronta SNOA con altri titoli

Sonoma Pharmaceuticals Inc Borsa (SNOA) Ultime notizie

Scar Management Market Top PlayersNewmedical Technology - openPR

Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors - Yahoo Finance

SNOA's Wound Care Products Get Regulatory Clearance, LFMD's Q4 Revenue Soars, ATRA On Watch - RTTNews

Sonoma Pharmaceuticals expands into UK market By Investing.com - Investing.com Australia

Sonoma Pharmaceuticals expands into UK market - Investing.com India

Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - ACCESS Newswire

Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga

Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 25% Lower - Simply Wall St

SNOA stock touches 52-week low at $2 amid market challenges - Investing.com Australia

SNOA stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa

Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Scar Treatment Market Projected To Witness Massive Growth, - openPR

Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga

Virpax Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:VRPX - Benzinga

Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff - ACCESS Newswire

SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges By Investing.com - Investing.com South Africa

SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges - Investing.com

Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando - ACCESS Newswire

How Sonoma Pharmaceuticals Plans to Expand Its Dermatology Footprint at Major 2025 Industry Event - StockTitan

Investor Network: Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Sonoma Pharmaceuticals secures new supply agreement - MSN

SNOA stock touches 52-week low at $2.44 amid market challenges - Investing.com Canada

Sonoma County earmarks opioid settlement money for treatment, education programs - MSN

More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown - Yahoo Finance

CNS Pharma (NASDAQ:CNSP) Stock Quotes, Forecast and News Summary - Benzinga

Head-To-Head Survey: Sonoma Pharmaceuticals (NASDAQ:SNOA) and BrainsWay (NASDAQ:BWAY) - Defense World

Redhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary - Benzinga

Head-To-Head Survey: Sonoma Pharmaceuticals (NASDAQ:SNOA) vs. Femasys (NASDAQ:FEMY) - Defense World

Keloid Treatment Market in 2022: Forecast to Reach $4.72 Bn by 2031. - openPR

Is Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Worth US$2.7 Based On Its Intrinsic Value? - Yahoo Finance

Sonoma Pharmaceuticals (SNOA) to Release Quarterly Earnings on Thursday - Defense World

Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 - Marketscreener.com

Sonoma Pharmaceuticals Inc. (SNOA) reports earnings - Quartz

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results - ACCESS Newswire

Earnings Alert: Sonoma Pharma Delivers Double-Digit Growth, Secures Major Distribution Deals - StockTitan

Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Sonoma Pharmaceuticals secures new supply agreement By Investing.com - Investing.com Canada

Dental Market Future Business Opportunities 2025-2032 | - openPR

Hypertrophic And Keloid Scar Treatment Global Market Expected To Ascend to $12.51 Billion By 2029 - WhaTech

Sonoma Pharmaceuticals (SNOA) Stock Surges Amid Industry Decline - GuruFocus.com

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - ACCESS Newswire

Sonoma Pharmaceuticals to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany - ACCESS Newswire

Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores - ACCESS Newswire

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea - ACCESS Newswire

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections - ACCESS Newswire

Sonoma Pharmaceuticals Inc Azioni (SNOA) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a SNOA